Drug discovery and development specialist e-Therapeutics announced today it had been granted a US patent for a further key process in its drug discovery platform.
129407
E-Therapeutics granted US patent for key process
5208
GenMark enters into license agreement with PerkinElmer for microfluidics patent portfolio
31641
Simmons Simmons elexica > Towards a single, pan-European patent standard
86160
Tekmira Pharmaceuticals receives $2.4 million grant from National Institutes of Health
142671
International Business Machines assigned patent for firewall control via process interrogation
25549
Scientists working on a new cancer drug
51712
International Business Machines assigned patent for instrumenting a compiled software routine for augmentation
10934
FDA lifts partial hold on Icagen drug;
154009
Symbol Technologies assigned patent
75604
FDA approves expanded indication for cardiac resynchronization therapy
159944
AstraZeneca wins key battle
18750
Mondo receives US patents on new artificial turf backing
88639
ICON selected as Pfizer strategic partner
150113
Boston Scientific receives CE Mark approval for spinal cord stimulator system
123993
FDA approves new drug for multiple sclerosis
50957
Embarq publishes patent application
98524
An oral agent for the treatment of moderate to severe psoriasis would earn a higher patient share in the United States than in Europe